Cargando…
N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization
Many immune responses depend upon activation of NF-κB, an important transcription factor in the elicitation of a cytokine response. Here we show that N4BP1 inhibits TLR-dependent activation of NF-κB by interacting with the NF-κB signaling essential modulator (NEMO, also known as IκB kinase γ) to att...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925594/ https://www.ncbi.nlm.nih.gov/pubmed/33654074 http://dx.doi.org/10.1038/s41467-021-21711-5 |
_version_ | 1783659302781714432 |
---|---|
author | Shi, Hexin Sun, Lei Wang, Ying Liu, Aijie Zhan, Xiaoming Li, Xiaohong Tang, Miao Anderton, Priscilla Hildebrand, Sara Quan, Jiexia Ludwig, Sara Moresco, Eva Marie Y. Beutler, Bruce |
author_facet | Shi, Hexin Sun, Lei Wang, Ying Liu, Aijie Zhan, Xiaoming Li, Xiaohong Tang, Miao Anderton, Priscilla Hildebrand, Sara Quan, Jiexia Ludwig, Sara Moresco, Eva Marie Y. Beutler, Bruce |
author_sort | Shi, Hexin |
collection | PubMed |
description | Many immune responses depend upon activation of NF-κB, an important transcription factor in the elicitation of a cytokine response. Here we show that N4BP1 inhibits TLR-dependent activation of NF-κB by interacting with the NF-κB signaling essential modulator (NEMO, also known as IκB kinase γ) to attenuate NEMO–NEMO dimerization or oligomerization. The UBA-like (ubiquitin associated-like) and CUE-like (ubiquitin conjugation to ER degradation-like) domains in N4BP1 mediate interaction with the NEMO COZI domain. Both in vitro and in mice, N4bp1 deficiency specifically enhances TRIF-independent (TLR2, TLR7, or TLR9-mediated) but not TRIF-dependent (TLR3 or TLR4-mediated) NF-κB activation, leading to increased production of proinflammatory cytokines. In response to TLR4 or TLR3 activation, TRIF causes activation of caspase-8, which cleaves N4BP1 distal to residues D424 and D490 and abolishes its inhibitory effect. N4bp1(−/−) mice also have diminished numbers of T cells in the peripheral blood. Our work identifies N4BP1 as an inhibitory checkpoint protein that must be overcome to activate NF-κB, and a TRIF-initiated caspase-8-dependent mechanism by which this is accomplished. |
format | Online Article Text |
id | pubmed-7925594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79255942021-03-21 N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization Shi, Hexin Sun, Lei Wang, Ying Liu, Aijie Zhan, Xiaoming Li, Xiaohong Tang, Miao Anderton, Priscilla Hildebrand, Sara Quan, Jiexia Ludwig, Sara Moresco, Eva Marie Y. Beutler, Bruce Nat Commun Article Many immune responses depend upon activation of NF-κB, an important transcription factor in the elicitation of a cytokine response. Here we show that N4BP1 inhibits TLR-dependent activation of NF-κB by interacting with the NF-κB signaling essential modulator (NEMO, also known as IκB kinase γ) to attenuate NEMO–NEMO dimerization or oligomerization. The UBA-like (ubiquitin associated-like) and CUE-like (ubiquitin conjugation to ER degradation-like) domains in N4BP1 mediate interaction with the NEMO COZI domain. Both in vitro and in mice, N4bp1 deficiency specifically enhances TRIF-independent (TLR2, TLR7, or TLR9-mediated) but not TRIF-dependent (TLR3 or TLR4-mediated) NF-κB activation, leading to increased production of proinflammatory cytokines. In response to TLR4 or TLR3 activation, TRIF causes activation of caspase-8, which cleaves N4BP1 distal to residues D424 and D490 and abolishes its inhibitory effect. N4bp1(−/−) mice also have diminished numbers of T cells in the peripheral blood. Our work identifies N4BP1 as an inhibitory checkpoint protein that must be overcome to activate NF-κB, and a TRIF-initiated caspase-8-dependent mechanism by which this is accomplished. Nature Publishing Group UK 2021-03-02 /pmc/articles/PMC7925594/ /pubmed/33654074 http://dx.doi.org/10.1038/s41467-021-21711-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Shi, Hexin Sun, Lei Wang, Ying Liu, Aijie Zhan, Xiaoming Li, Xiaohong Tang, Miao Anderton, Priscilla Hildebrand, Sara Quan, Jiexia Ludwig, Sara Moresco, Eva Marie Y. Beutler, Bruce N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization |
title | N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization |
title_full | N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization |
title_fullStr | N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization |
title_full_unstemmed | N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization |
title_short | N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization |
title_sort | n4bp1 negatively regulates nf-κb by binding and inhibiting nemo oligomerization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925594/ https://www.ncbi.nlm.nih.gov/pubmed/33654074 http://dx.doi.org/10.1038/s41467-021-21711-5 |
work_keys_str_mv | AT shihexin n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT sunlei n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT wangying n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT liuaijie n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT zhanxiaoming n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT lixiaohong n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT tangmiao n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT andertonpriscilla n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT hildebrandsara n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT quanjiexia n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT ludwigsara n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT morescoevamariey n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization AT beutlerbruce n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization |